When Can Children With Conditions Be in No-Benefit, Higher-Hazard Pediatric Studies?

By Kopelman Loretta  

American Journal of Bioethics, Vol. 7, Iss. 3, 2007-03 ,pp. : 15-17

Routledge Ltd

Access to resources Recommend Favorite

Determining Risk in Pediatric Research with No Prospect of Direct Benefit: Time for a National Consensus on the Interpretation of Federal Regulations

By Fisher Celia   Kornetsky Susan   Prentice Ernest  

American Journal of Bioethics, Vol. 7, Iss. 3, 2007-03 ,pp. : 5-10

Routledge Ltd

Access to resources Recommend Favorite

The Role of Controversial Research in the IRB's Risk/Benefit Analysis

By Lunstroth John  

American Journal of Bioethics, Vol. 11, Iss. 5, 2011-05 ,pp. : 14-16

Routledge Ltd

Access to resources Recommend Favorite

When "Risk" and "Benefit" Are Open to Interpretation - As Is Generally the Case

By Spriggs Merle  

American Journal of Bioethics, Vol. 7, Iss. 3, 2007-03 ,pp. : 17-19

Routledge Ltd

Access to resources Recommend Favorite

Stakeholder Perspectives on a Risk-Benefit Framework for Genetic Testing

By  

Public Health Genomics, Vol. 14, Iss. 2, 2010-04 ,pp. : 59-67

Karger

Access to resources Recommend Favorite